Reports
Sale
Global Transcatheter Heart Valve Replacement and Repair Market: By Procedure: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Repair (TMVR), Transcatheter Pulmonary Valve Replacement (TPVR); By Indication: Aortic Stenosis, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Transcatheter Heart Valve Replacement and Repair Market Outlook
The global transcatheter heart valve replacement and repair market size was valued at USD 5.71 billion in 2023, driven by the increasing prevalence of cardiovascular diseases across the globe. The market is expected to grow at a CAGR of 12% during the forecast period of 2024-2032, with the values likely to rise from USD 6.40 billion in 2024 to USD 15.84 billion by 2032.
Transcatheter Heart Valve Replacement and Repair: Introduction
Transcatheter aortic valve replacement and repair are procedures done to treat a stiff (calcified) or thickened aortic valve that cannot fully open (aortic stenosis). The aortic valve is located between left ventricle (lower heart chamber) and aorta (body's main artery). If this valve does not open properly, blood flow from heart to other parts is compromised and the heart is forced to work harder.
Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure that helps avoid the need for open heart surgery in a patient. TAVR can help a patient live a prolonged and comfortable life by restoring blood flow and reducing the symptoms of aortic valve stenosis like chest pain (angina) or tightness, shortness of breath, fluttering heartbeat (palpitations), an irregular heart sound (heart murmur) heard through a stethoscope, fainting and fatigue. Transcatheter aortic valve replacement (TAVR) is also called transcatheter aortic valve implantation (TAVI).
Global Transcatheter Heart Valve Replacement and Repair Market Analysis
Congenital heart defect is a major cause of aortic valve stenosis. It is the most common congenital disorder, responsible for about 28% of all congenital birth defects. In this defect, children are born with an aortic valve that has only two cusps instead of three. Children born with this defect require regular medical checkups. It may not cause any problems until adulthood but if the valve begins to narrow or leak, it may need to be repaired or replaced. With approximately 1.35 million babies born with CHD each year globally, the transcatheter heart valve replacement and repair market has experienced a parallel growth, driven by the increasing number of patients necessitating treatment.
Coronary artery calcification (CAC), which is highly prevalent in patients with coronary heart disease, grows with aging. By the time a person touches 70 or 80 years, calcium deposit starts on the valves. The stiffening valves need to be treated in time to avoid early demise. Hence, regions with increasing geriatric population are anticipated to observe a growth in the transcatheter heart valve replacement and repair market share.
Given the prevailing lifestyle characterized by obesity, high stress, blood pressure, and glucose levels, people are already at the risk of heart failures and open-heart surgeries. If such patterns persist, the prevalence of cardiovascular diseases is expected to escalate in the near future, potentially undergoing TAVR or TAVI to maintain a healthy life. As a result, there is a projected global expansion in the market size for transcatheter heart valve replacement and repair.
Global Transcatheter Heart Valve Replacement and Repair Market Segmentation
Market Breakup by Procedure
- Transcatheter Aortic Valve Replacement (TAVR)
- Transcatheter Mitral Valve Repair (TMVR)
- Transcatheter Pulmonary Valve Replacement (TPVR)
Market Breakup by Indication
- Aortic Stenosis
- Mitral Regurgitation
- Aortic Regurgitation
- Mitral Stenosis
- Tricuspid Regurgitation
Market Breakup by End User
- Hospitals
- Cardiac Catheterization Laboratories
- Ambulatory Surgical Centres
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Transcatheter Heart Valve Replacement and Repair Market Overview
There have been significant advancements in the field of cardiac sciences, despite the high prevalence of patients with some or the other form of cardiac disease. Medtronic's next-generation Evolut FX system is refined with gold markers built into the frame of the implant to visualise the implant depth and location better. Abbott's Portico with FlexNav TAVI System requires 76% less insertion force than their previous products. It is evident that the healthcare industry is growing to develop high-quality and innovative techniques to facilitate the procedures to precision.
Whether considering the highest number of cases or significant innovations, the North American region has been a focal point for the global transcatheter heart valve replacement and repair market development. Nonetheless, an anticipation of substantial demand is indicated towards the Asian region, primarily linked to its increasing emphasis on healthcare. The Asian territory constitutes to the maximum aging population globally. Hence, the prevalence of aortic stenosis and the cardiac surgical interventions are likely to increase, and the market size can expand in the future.
Global Transcatheter Heart Valve Replacement and Repair Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Edwards Lifesciences Corporation
- Medtronic
- Abbott
- Boston Scientific Corporation
- B. Braun SE
- MicroPort Scientific Corporation
- Meril Life Sciences Pvt. Ltd.
- Sahajanand Medical Technologies Limited
- Venus Medtech (Hangzhou) Inc.
- Peijia Medical Limited
- Blue Sail Medical Co Ltd
- Penumbra, Inc.
- Encapson
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Procedure |
|
| Breakup by Indication |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Transcatheter Heart Valve Replacement and Repair Market Overview
3.1 Global Transcatheter Heart Valve Replacement and Repair Market Historical Value (2017-2023)
3.2 Global Transcatheter Heart Valve Replacement and Repair Market Forecast Value (2024-2032)
4 Global Transcatheter Heart Valve Replacement and Repair Market Landscape
4.1 Global Transcatheter Heart Valve Replacement and Repair Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Transcatheter Heart Valve Replacement and Repair Product Landscape
4.2.1 Analysis by Procedure
4.2.2 Analysis by Indication
5 Global Transcatheter Heart Valve Replacement and Repair Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Transcatheter Heart Valve Replacement and Repair Market Segmentation
6.1 Global Transcatheter Heart Valve Replacement and Repair Market by Procedure
6.1.1 Market Overview
6.1.2 Transcatheter Aortic Valve Replacement (TAVR)
6.1.3 Transcatheter Mitral Valve Repair (TMVR)
6.1.4 Transcatheter Pulmonary Valve Replacement (TPVR)
6.2 Global Transcatheter Heart Valve Replacement and Repair Market by Indication
6.2.1 Market Overview
6.2.2 Aortic Stenosis
6.2.3 Mitral Regurgitation
6.2.4 Aortic Regurgitation
6.2.5 Mitral Stenosis
6.2.6 Tricuspid Regurgitation
6.3 Global Transcatheter Heart Valve Replacement and Repair Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Cardiac Catheterization Laboratories
6.3.4 Ambulatory Surgical Centres
6.3.5 Others
6.4 Global Transcatheter Heart Valve Replacement and Repair Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Transcatheter Heart Valve Replacement and Repair Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Transcatheter Heart Valve Replacement and Repair Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Transcatheter Heart Valve Replacement and Repair Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Transcatheter Heart Valve Replacement and Repair Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Transcatheter Heart Valve Replacement and Repair Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Edwards Lifesciences Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Medtronic
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Abbott
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Boston Scientific Corporation
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 B. Braun SE
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 MicroPort Scientific Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Meril Life Sciences Pvt. Ltd.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Sahajanand Medical Technologies Limited
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Venus Medtech (Hangzhou) Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Peijia Medical Limited
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Blue Sail Medical Co Ltd
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Penumbra, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Encapson
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Transcatheter Heart Valve Replacement and Repair Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 5.71 billion in 2023 driven by the increasing volume of aging population and extensive research and innovations in healthcare industry.
The market is anticipated to grow at a CAGR of 12% during the forecast period of 2024-2032, likely to reach a market value of USD 15.84 billion by 2032.
The market demand is expected to grow with the rising cases to cardiovascular diseases across the globe and the rapid technological advancements in the healthcare sector.
The North American region has been the biggest market in the historical period. However, the Asian region is expected to observe a growth, due to the high geriatric population in the area.
The procedures include transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair (TMVR), and transcatheter pulmonary valve replacement (TPVR). The procedure may vary depending upon the patient’s requirement.
Doctors advise a person to undergo the procedure if they are suffering from aortic stenosis, mitral regurgitation, aortic regurgitation, mitral stenosis, or tricuspid regurgitation.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
The end users in the market include hospitals, ambulatory surgical centre, cardiac catheterization laboratories, and others.
Key players involved in the market are Edwards Lifesciences Corporation, Medtronic, Abbott, Boston Scientific Corporation, B. Braun SE, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Sahajanand Medical Technologies Limited, Venus Medtech (Hangzhou) Inc., Peijia Medical Limited, Blue Sail Medical Co Ltd, Penumbra, Inc. and Encapson.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER